专题：Myasthenia Gravis and Thymoma

This cluster of papers focuses on the research related to myasthenia gravis, including its subgroups, clinical correlates, treatment strategies, and the role of autoantibodies. Additionally, it explores the classification and prognosis of thymic tumors, the efficacy of thymectomy, and the epidemiology of these conditions.
最新文献
Inflammatory Myopathies

review Full Text OpenAlex

Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial

article Full Text OpenAlex

European Society of Neuroendocrine Tumors ( ENETS ) 2025 guidance paper for lung and thymic carcinoids

article Full Text OpenAlex

A Phase 3 Trial of Brepocitinib in Dermatomyositis

article Full Text OpenAlex

Thymic health consequences in adults

article Full Text OpenAlex

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases

article Full Text OpenAlex

Age-related thymic involution: Mechanistic insights and rejuvenating approaches to restore immune function

review Full Text OpenAlex

Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies

article Full Text OpenAlex

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

article Full Text OpenAlex

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

article Full Text OpenAlex

近5年高被引文献
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

article Full Text OpenAlex 294 FWCI42.1419

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

article Full Text OpenAlex 282 FWCI40.8169

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

article Full Text OpenAlex 282 FWCI40.7832

CD19-targeted CAR T cells in refractory antisynthetase syndrome

article Full Text OpenAlex 261 FWCI42.9396

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

article Full Text OpenAlex 254 FWCI23.8405

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome

article Full Text OpenAlex 251 FWCI41.5164

Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association

article Full Text OpenAlex 245 FWCI20.9529

Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis

article Full Text OpenAlex 244 FWCI21.1981

Trial of Intravenous Immune Globulin in Dermatomyositis

article Full Text OpenAlex 229 FWCI26.8457

Age‐related thymic involution: Mechanisms and functional impact

article Full Text OpenAlex 220 FWCI11.3891